Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06545604

Comprehensive Yoga Therapy Based Lifestyle Prehabilitation Program for Women With Ovarian Cancer

To provide a comprehensive yoga therapy (CYT) program to patients with ovarian, fallopian tube, or primary peritoneal cancer who are scheduled to receive chemotherapy and then undergo surgery. Researchers want to learn about the effects of the program on patients' quality of life and other outcomes described below.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

MD Anderson Cancer Center

Houston, Texas, 77030, United States

Location status: Recruiting

Location contact

Lois Ramondetta, MD

CONTACT

[email protected]

713-745-0307

About this study

Primary Objectives:

Primary Objective: to assess the feasibility of a CYT prehabilitation program in women with ovarian cancer scheduled to receive NACT and IDS. Feasibility criteria will include the percent of eligible patients who consent to participate (feasibility is defined as 30% of those approached and are eligible end up consenting) and study retention by the last follow-up (feasibility is defined as 60% of those undergoing surgery remaining in the study and providing some data at baseline and at last follow-up timepoint).

Secondary Objectives:

  • Examine the effects of the CYT program on physical conditioning as assessed by the 2-minute step test (2MST) and sit to stand reps (30secSTS) compared with WLC.
  • Examine group differences in surgical outcomes including post op stay, readmission rate, post op morbidity, surgical site infection rate, , and time to first chemotherapy post operatively.
  • Examine group differences in patient-reported outcomes including QOL, fatigue, stress, sleep disturbances, mental health, social support, and mindfulness.
  • Examine if there are group differences in preoperative albumin level, vit D, magnesium levels.
  • Examine group differences and changes over time in microbiome biodiversity.
  • Examine group differences in body composition (sarcopenia) as measured by routine abdominal CT scans.
  • Explore the association between adherence to the components of CYT with ability to sustain behavior changes and between changes in lifestyle parameters with outcomes. This will be explored both within and across groups.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women with stage III-IV epithelial ovarian, fallopian tube, primary peritonal cancer with recommendations for NACT/IDS at recruitment.
  • Able to read, write, and speak English.
  • 18 years of age or older.
  • Oriented to person, place, and time.
  • Access to internet connection.
  • Access to a tablet, laptop or computer or smart phone.
  • Access and ability to do virtual sessions.
  • Plan for surgical intervention at MD Anderson Cancer Center 9. Performance status 0-2.

Exclusion criteria

  • Have completed chemotherapy.
  • Any major thought disorder (e.g., schizophrenia, dementia).
  • Any major communication barriers that would preclude being able to complete the intervention (e.g., visually or hearing impaired).
  • Extreme mobility issues (e.g., unable to get in and out of a chair unassisted).
  • Have a regular mind-body practice or an established yoga practice.

Treatment and study plan

Yoga Therapy for Nutritional, Physical, and Psychosocial Prehabilitation

Other

Two visits per week with a yoga therapist while receiving neoadjuvant chemotherapy to cover dietary counseling, yoga-based movement practices, breathwork practices, mind practices, and behavioral support for the purpose of preparing patients' mind and body for a planned surgery.

Usual care supportive services including nutrition counseling per usual care

Other

Usual care supportive services while receiving neoadjuvant chemotherapy.

Primary outcomes

  1. To assess the feasibility of a CYT prehabilitation program in women with ovarian cancer scheduled to receive NACT and IDS.

    Time frame: Through study completion; an average of 1 year

Study contacts

Contact information is provided by the study sponsor or research team.

Lois Ramondetta, MD

CONTACT

[email protected]

(713) 745-0307

Sponsors and collaborators

Lead sponsor

M.D. Anderson Cancer Center

Other

Registry information

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Aug 9, 2024
Registry last updated
Nov 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.